Orofar Lidocain Perlen Mit Minzgeschmack (Benzoxonium Chloride, Lidocaine Hydrochloride)

Lidocaine and Benzoxonium chloride, the active ingredients in Orofar Lidocain Perlen Mit Minzgeschmack, are a local anesthetic and antiseptic presented as oral pearls for oral use. They provide temporary numbing and antimicrobial protection for minor oral discomfort in adults and children.

GNH USA supplies Orofar Lidocain Perlen Mit Minzgeschmack as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orofar Lidocain Perlen Mit Minzgeschmack, containing lidocaine and benzoxonium chloride, is used for local oral discomfort and minor mucosal lesions.

- Oral mucosal irritation: provides temporary numbing and reduces pain. - Minor aphthous ulcers: alleviates discomfort and promotes soothing. - Post‑procedural oral soreness: offers local anesthesia to ease sensitivity.

Adverse reactions may occur with oral administration of the pearls.

Common Side Effects: - Mild burning sensation at the site of application. - Transient numbness lasting beyond the intended period. - Altered taste perception (metallic or minty). - Mild oral irritation or redness.

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling or itching. - Severe oral ulceration or tissue necrosis. - Anaphylaxis with respiratory distress and hypotension. - Persistent numbness indicating possible systemic absorption. - Unexplained cardiac arrhythmia in susceptible individuals.

Before using Orofar Lidocain Perlen Mit Minzgeschmack, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anaesthetics or quaternary ammonium compounds. - Age limitation: use with caution in children under six years unless directed by a clinician. - Systemic exposure: avoid excessive use that could lead to systemic lidocaine toxicity. - Oral lesions: do not apply on extensive open wounds or severe infections without medical advice. - Drug interactions: review concomitant medications that may affect lidocaine metabolism. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lidocaine and benzoxonium chloride may interact with other substances.

Major Interactions (Avoid): - Concurrent use with other topical anesthetics: risk of additive systemic toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase lidocaine plasma levels. - MAO inhibitors: potential for hypertensive reactions when combined with sympathomimetic agents.

Moderate Interactions (Monitor Closely): - Alcohol consumption: can enhance central nervous system depression. - Beta‑blockers: may potentiate lidocaine's cardiac effects. - Anticonvulsants: could lower seizure threshold when combined with lidocaine. - Herbal supplements (e.g., St. John’s wort): may alter lidocaine metabolism. - Electrolyte disturbances (hypokalemia): increase risk of cardiac arrhythmias.